ESC 365 - Vericiguat and SGLT2 inhibitors.

ESC Premium Access

Vericiguat and SGLT2 inhibitors.

Session: New therapies in heart failure with reduced ejection fraction: For whom and when?

Topic: Chronic Heart Failure

Speaker: Professor C. Lam (Singapore, SG)

Event: ESC Asia with APSC & AFC 2020

Congress Presentation

About the speaker

Professor Carolyn Sp Lam

Duke-NUS Graduate Medical School Singapore, Singapore (Singapore)

150 presentations

51 followers

2 more presentations in this session

Sacubitril valsartan, ivabradine and omecamtic mecarbil.

Speaker: Professor M. Komajda (Paris, FR)

New therapies in heart failure with reduced ejection fraction: For whom and when?

Access the full session

New therapies in heart failure with reduced ejection fraction: For whom and when?

Speakers: Professor C. Lam, Professor M. Komajda

About the event

ESC Asia with APSC & AFC 2020

3 December - 5 December 2020

Sessions Presentations

Congress

ESC 365 is supported by